Trifenmorph, also known as tridemorph, is a fungicide used to control powdery mildew in various crops. It is synthesized through a series of reactions involving chlorination, alkylation, and condensation. Trifenmorph inhibits the biosynthesis of ergosterol, a crucial component of fungal cell membranes, leading to disruption of cell growth and development. It exhibits both preventive and curative action against powdery mildew. Due to its effectiveness and relatively low toxicity to mammals, trifenmorph is widely used in agriculture. However, concerns regarding its potential environmental impact and the emergence of resistant fungal strains have led to ongoing research on its mode of action, alternative fungicides, and sustainable practices.'
trifenmorph: structure
ID Source | ID |
---|---|
PubMed CID | 14993 |
CHEMBL ID | 2086832 |
CHEBI ID | 82264 |
SCHEMBL ID | 435727 |
MeSH ID | M0042375 |
Synonym |
---|
unii-h1il51k9cw |
h1il51k9cw , |
trifenmorph [iso:bsi] |
caswell no. 898a |
wl 8008 |
einecs 215-812-2 |
triphenmorphe |
ai3-51843 |
morpholine, n-trityl- |
n-tritylmorpholine |
frescon |
n-(triphenyl-methyl)morpholine |
epa pesticide chemical code 498300 |
morpholine, 4-(triphenylmethyl)- |
morpholine, 4-trityl- |
trifenmorph |
4-tritylmorpholine |
hsdb 1785 |
shell wl 8008 |
brn 1223254 |
4-(triphenylmethyl)morpholine |
NCGC00160549-01 |
AKOS003382578 |
C19144 |
1420-06-0 |
chebi:82264 , |
CHEMBL2086832 |
trifenmorph [hsdb] |
trifenmorph [mart.] |
trifenmorph [mi] |
trifenmorph [iso] |
SCHEMBL435727 |
n-(triphenylmethyl)morpholine |
DTXSID6042492 |
4-tritylmorpholine # |
Q27155848 |
Excerpt | Reference | Relevance |
---|---|---|
" This order was the same in oligocalcic water with Echinogammarus berilloni; with Gammarus pulex, CuCl2 was more toxic than Triphenmorph." | ( [Comparative study of the toxicity of metal chlorides and a synthetic organic molluscacide, N-tritylmorpholine, in 2 fresh-water amphipods, Gammarus pulex and Echinogammarus berilloni]. Debord, J; Penicaut, B; Vincent, M, 1986) | 0.27 |
Class | Description |
---|---|
morpholines | Any compound containing morpholine as part of its structure. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID684467 | Inhibition of apolipoprotein E production in human CCF-STTG1 cells at 10 uM after 24 hrs by ELISA relative to vehicle-treated control | 2012 | Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19 | Design, synthesis and identification of a new class of triarylmethyl amine compounds as inhibitors of apolipoprotein E production. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 12 (85.71) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (16.52) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (13.33%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (86.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |